IP Library Granted Patent US 11,371,092
Granted Patent B2
US 11,371,092 · App. 15/256,047 · Granted Jun 28, 2022

Detection device and methods of use

Inventors: Steven Gordon (Weston, MA); Steven Auger (Cohasset, MA); Alan Schinazi (Providence, RI)
Assignee: QIAGEN SCIENCES, LLC
C12Q1/6874G01N21/6428G01N21/6452G01N21/6486G01N21/05G01N2021/0325G01N2021/6421G01N2021/6441G01N2021/6471
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,371,092
App. No.
15/256,047
Granted
Jun 28, 2022
Kind
B2
Abstract

An imaging system for exciting and measuring fluorescence on or in samples comprising fluorescent materials (e.g. fluorescent labels, dyes or pigments). In one embodiment, a device is used to detect fluorescent labels on nucleic acid. In a preferred embodiment, the device is configured such that fluorescent labels in a plurality of different DNA templates are simultaneously detected.

Claims (40)

1. A method comprising:

a) providing an imaging system, said imaging system comprising

i) a non-lasing light source, emitting different wavelengths of light, configured such that the emitted visible light from said source illuminates a portion of a flow cell,

ii) said flow cell comprising an array of biomolecules on a surface, wherein said emitted light illuminates said surface, wherein said array faces inwardly so that reagents introduced in solution can contact said biomolecules, wherein said flow cell comprises a fluidic connection to at least one reagent bottle wherein said at least one reagent bottle is under a positive pressure,

iii) a lens positioned to collect a portion of a visible fluorescence; and

iv) a camera;

b) introducing a solution via said fluidic connection into said flow cell, said solution comprising a plurality of fluorescent compounds having different excitation and emission wavelengths, under conditions such that a portion of said fluorescent compounds attaches to a portion of said array of biomolecules, so as to create treated biomolecules,

c) illuminating said flow cell with said light source emitting different wavelengths of light, wherein said emitted visible light from said source converges on said fluorescent compounds, and

d) concurrently imaging said treated biomolecules illuminated with said light source emitting different wavelengths of light with said imaging system.

2. The method of claim 1 , wherein said flow cell is transparent.

3. The method of claim 1 , wherein said array of biomolecules comprises an array of nucleic acid.

4. The method of claim 1 , wherein said fluorescent compounds comprise labeled nucleotides.

5. The method of claim 4 , wherein said solution of step b) further comprises polymerase.

6. The method of claim 1 , further comprising, prior to step d) removing said solution from said flow cell.

7. The method of claim 6 , wherein said removing is achieved in part by gravity.

8. The method of claim 1 , wherein said flow cell is connected to a fluidics system.

9. The method of claim 1 , wherein said solution is under positive pressure and is introduced at step b) by controlled valving.

10. A method comprising:

a) providing an imaging system, said imaging system comprising

i) first, second, third and fourth non-lasing light sources, each source emitting a different wavelength of visible light and configured such that the emitted light from said source illuminates a portion of a flow cell,

ii) said flow cell comprising an array of biomolecules positioned so that reagents introduced in solution can contact said biomolecules, wherein said flow cell comprises a fluidic connection to at least one reagent bottle wherein said at least one reagent bottle is under a positive pressure,

iii) a lens positioned to collect a portion of a visible fluorescence; and

iv) a camera;

b) introducing a solution via said fluidic connection into said flow cell, said solution comprising a plurality of fluorescent compounds having different excitation and emission wavelengths, under conditions such that a portion of said fluorescent compounds attaches to a portion of said array of biomolecules, so as to create treated biomolecules,

c) illuminating said flow cell with said light source emitting different wavelengths of light, and

d) concurrently imaging said treated biomolecules illuminated with said light source emitting different wavelengths of light with said imaging system.

11. The method of claim 10 , wherein said light sources are light emitting diodes.

12. The method of claim 10 , wherein two of said four wavelengths comprise 488 nm and 530 nm.

13. The method of claim 10 , wherein said flow cell comprises one or more flow channels, and said array of biomolecules is positioned in a channel under conditions such that said array contacts said solution upon said introducing of said solution of step (b).

14. The method of claim 12 , wherein one of said one or more flow channels has a first surface and a second surface, and wherein said array is positioned on said first surface.

15. A method comprising:

a) providing an imaging system, said imaging system comprising

i) first and second non-lasing light sources, each source emitting different wavelengths of visible light and configured such that the emitted light from said source illuminates a portion of a flow cell,

ii) said flow cell comprising biomolecules positioned so that reagents introduced in solution can contact said biomolecules, wherein said array of biomolecules comprises an array of nucleic acid, wherein said flow cell comprises a fluidic connection to at least one reagent bottle wherein said at least one reagent bottle is under a positive pressure,

iii) a lens positioned to collect a portion of a visible fluorescence; and

iv) a camera;

b) introducing a solution via said fluidic connection into said flow cell, said solution comprising a plurality of fluorescent compounds having different excitation and emission wavelengths, under conditions such that a portion of said fluorescent compounds attaches to a portion of said biomolecules, so as to create treated biomolecules,

c) illuminating said flow cell with said light source emitting different wavelengths of light, wherein said emitted visible light from said source converges on said fluorescent compounds, and

d) concurrently imaging said treated biomolecules illuminated with said light source emitting different wavelengths of light with said imaging system.

16. The method of claim 15 , wherein said light sources are light emitting diodes.

Assignments (4)
AMENDED PATENT PURCHASE AGREEMENT Recorded Jul 7, 2022
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 060614/0455 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2017
From: GORDON, STEVEN; AUGER, STEVEN; SCHINAZI, ALAN
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 043286/0436 →
Continuity (5)
Continuation 14539244 · Nov 12, 2014
Continuation 12704842 · Feb 12, 2010
Continuation 12020284 · Jan 25, 2008
Provisional Application 60899454 · Feb 5, 2007
Related Publication 20160369337A1 · Dec 22, 2016
Cited By (2)
US 12,227,798 US 12,656,313